These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 2779868)
21. [Resistance to rHuEPO]. Sułowicz W Przegl Lek; 1995; 52(3):88-9. PubMed ID: 7644681 [No Abstract] [Full Text] [Related]
22. Human recombinant erythropoietin: progress in clinical development. Kubiak W; Karwacki M; Mazur I Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():39-50. PubMed ID: 8192531 [No Abstract] [Full Text] [Related]
23. FDA panel unanimously recommends approval of Vistide for CMV retinitis. Food and Drug Administration. J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50. PubMed ID: 11363532 [TBL] [Abstract][Full Text] [Related]
24. EPO (epoetin) approval stirs cost concern in Congress. Wagner M Mod Healthc; 1989 Jun; 19(23):4. PubMed ID: 10293460 [No Abstract] [Full Text] [Related]
25. FDA taps anti-emetic for treatment of AIDS complication. RN; 1993 Apr; 56(4):93. PubMed ID: 8386850 [No Abstract] [Full Text] [Related]
26. FDA approves the distribution of AZT for children. J Pract Nurs; 1989 Dec; 39(4):9. PubMed ID: 2600877 [No Abstract] [Full Text] [Related]
27. FDA approves an AIDS drug from Vertex. Food and Drug Administration. Newsline People AIDS Coalit N Y; 1999; ():32. PubMed ID: 11367345 [TBL] [Abstract][Full Text] [Related]
29. Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin. Barlogie B Semin Hematol; 1993 Oct; 30(4 Suppl 6):25-7. PubMed ID: 8153675 [TBL] [Abstract][Full Text] [Related]
30. Wasting syndrome: oral oxandrolone re-released in U.S. James JS AIDS Treat News; 1995 Dec; (no 237):3-4. PubMed ID: 11363076 [TBL] [Abstract][Full Text] [Related]
31. FDA notifications. Watch out for counterfeit Procrit, 2 lot numbers. AIDS Alert; 2002 Aug; 17(8):101-2. PubMed ID: 12647690 [No Abstract] [Full Text] [Related]
32. FDA reform in Congress: AIDS community absent. Food and Drug Administration. James JS AIDS Treat News; 1995 Apr; (no 220):4-5. PubMed ID: 11362320 [TBL] [Abstract][Full Text] [Related]
33. Clinical application of recombinant erythropoietin in anemic cancer patients. Henry DH Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218 [TBL] [Abstract][Full Text] [Related]
34. FDA moves ahead in the fight against AIDS. Glaser V N Y State J Med; 1988 May; 88(5):285. PubMed ID: 3380395 [No Abstract] [Full Text] [Related]
35. Clinical trial that led to FDA approval of zidovudine is published. Clin Pharm; 1987 Oct; 6(10):752. PubMed ID: 3333341 [No Abstract] [Full Text] [Related]
36. FDA considers home AIDS tests. Minn Med; 1994 Aug; 77(8):55. PubMed ID: 7935272 [No Abstract] [Full Text] [Related]
38. FDA launches "new use initiative". Nat Biotechnol; 1997 May; 15(5):399. PubMed ID: 9131604 [No Abstract] [Full Text] [Related]
39. Food and Drug Administration responses to the challenges of AIDS. Meyer HM Public Health Rep; 1983; 98(4):320-3. PubMed ID: 6193550 [TBL] [Abstract][Full Text] [Related]
40. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report. Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]